These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3215107)

  • 1. Gaps and perspectives of new fluoroquinolones.
    Neuman M; Esanu A
    Drugs Exp Clin Res; 1988; 14(6):385-91. PubMed ID: 3215107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M; Coll R; Esteve M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of trovafloxacin: its clinical significance].
    Clara LO; Biglia MA
    Medicina (B Aires); 1999; 59 Suppl 1():17-22. PubMed ID: 10436550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of some novel N-substituted piperazinyl-quinolones.
    Foroumadi A; Davood A; Mirzaei M; Emami S; Moshafi MH
    Boll Chim Farm; 2001; 140(6):411-6. PubMed ID: 11822230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety.
    Foroumadi A; Mohammadhosseini N; Emami S; Letafat B; Faramarzi MA; Samadi N; Shafiee A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):47-52. PubMed ID: 17206610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Kiechel JR; Remuzon P; Weber A; Oki T; Masuyoshi M; Kessler RE
    J Med Chem; 1990 May; 33(5):1344-52. PubMed ID: 2329555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity.
    Vancutsem PM; Babish JG; Schwark WS
    Cornell Vet; 1990 Apr; 80(2):173-86. PubMed ID: 2180631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory survey of fluoroquinolone activity.
    Bellido F; Pechère JC
    Rev Infect Dis; 1989; 11 Suppl 5():S917-24. PubMed ID: 2672262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of new quinolones containing a 7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl] moiety. Gram-positive agents with excellent oral activity and low side-effect potential.
    Hagen SE; Domagala JM; Gracheck SJ; Sesnie JA; Stier MA; Suto MJ
    J Med Chem; 1994 Mar; 37(6):733-8. PubMed ID: 8145222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New achievements in the fluoroquinolone problem: possibilities of increasing activity and expansion of the spectrum of action].
    Padeĭskaia EN
    Antibiot Khimioter; 1994 May; 39(5):52-65. PubMed ID: 7857163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of quinolones.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():197-9. PubMed ID: 8549302
    [No Abstract]   [Full Text] [Related]  

  • 17. [New fluoroquinolones: characteristics of antimicrobial effect and pharmacokinetics].
    Bondareva NS; Budanov SV
    Antibiot Khimioter; 1998; 43(8):28-33. PubMed ID: 9777103
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical evolution of the fluoroquinolone antimicrobial agents.
    Neu HC
    Am J Med; 1989 Dec; 87(6C):2S-9S. PubMed ID: 2557762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and the fluoroquinolones.
    Outman WR; Nightingale CH
    Am J Med; 1989 Dec; 87(6C):37S-42S. PubMed ID: 2690618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial activity of non-antibiotics: interactions with antibiotics.
    Neuman M
    APMIS Suppl; 1992; 30():15-23. PubMed ID: 1295541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.